Precision testing of tumor tissue for advanced cancers
Part of Cancer clinical trials.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis based on lab tests of tissue or cells
- Your cancer can be any type, including having more than one cancer at the same time
- You have a plan to get tumor tissue (through a biopsy or surgery) for research testing, or you already have leftover tumor tissue available
- Your doctor says it’s medically safe for you to have the tissue taken for testing
- You agree in writing to the study procedures before any study-related steps begin
- You can participate if you have a known or suspected inherited cancer risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “precision medicine” testing on your tumor (or planning to do it) can help guide possible targeted treatments for advanced cancer. It is observational, meaning researchers mainly watch and record what happens as testing results become available.
This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial takes a small sample of your tumor to grow a model in the lab. This model helps doctors test which treatments might work best for you.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.